← Back to Search

Neurostimulation Device

Active stimulation QD for Rheumatoid Arthritis

N/A
Waitlist Available
Led By Alan Kivitz, MD
Research Sponsored by SetPoint Medical Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment through month 36 (end of study)
Awards & highlights

Study Summary

This study is evaluating whether a device that stimulates the vagus nerve can be used to treat rheumatoid arthritis.

Eligible Conditions
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment through month 36 (end of study)
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment through month 36 (end of study) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence rates of Adverse Events
Secondary outcome measures
American College of Rheumatology (ACR) 20, 50 and 70 response rates
Change in Disease Activity Score (DAS) 28 - C-reactive protein (CRP)
Disease Activity Score (DAS) 28 - C-reactive protein (CRP) remission rate
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Active stimulation QDActive Control1 Intervention
Group II: Active stimulation QIDActive Control1 Intervention

Find a Location

Who is running the clinical trial?

SetPoint Medical CorporationLead Sponsor
6 Previous Clinical Trials
330 Total Patients Enrolled
4 Trials studying Rheumatoid Arthritis
300 Patients Enrolled for Rheumatoid Arthritis
Alan Kivitz, MDPrincipal InvestigatorAltoona Center for Clinical Research
7 Previous Clinical Trials
1,882 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
162 Patients Enrolled for Rheumatoid Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
2018. "Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04862117.
All > Rheumatoid Arthritis > Ra
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top